HomeNewsBusinessInterview | Indian airlines are burning cash of Rs 50 crore-Rs 60 crore daily, says ICRA’s Kinjal Shah

Interview | Indian airlines are burning cash of Rs 50 crore-Rs 60 crore daily, says ICRA’s Kinjal Shah

It may take a few more months before domestic aviation returns to levels of February this year, although business travel may take longer to recover.

June 29, 2021 / 21:59 IST
Story continues below Advertisement
Kinjal Shah, vice president & co-head, corporate ratings, at ICRA.
Kinjal Shah, vice president & co-head, corporate ratings, at ICRA.

Indian airlines are spending Rs 50 crore-60 crore every day during the second wave of COVID-19 as they operate at very low capacity since March due to lockdowns and restrictions in various states, said Kinjal Shah, vice president & co-head, corporate ratings, at ICRA.

In an interview with Moneycontrol, Shah said domestic airlines lost a sizable portion of their revenue as domestic air passenger traffic fell in April and May and it will take at least another few months to reach February 2021 levels. Edited excerpts:

Story continues below Advertisement

Due to the outbreak of the second wave of COVID-19, what are your expectations of revenue losses for both airlines and airport operators in the last few months?

There have definitely been revenue losses in the past few months, but if one looks at various parameters that determine the revenues of airlines, it is actually very difficult to project the revenue losses, one can project cash burn that can happen, but revenue losses are difficult to predict because it depends on the number of passengers carried, the route flown, the fare on that route, etc.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show